Report cover image

Escherichia Coli Strain Market

Publisher Coherent Market Insights
Published Aug 08, 2023
Length 160 Pages
SKU # CMI18163290

Description

Escherichia Coli Strain Market, By Application, By Pathogenicity, By Antibiotic Resistance, By Genetic Characteristics, By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Escherichia Coli, commonly known as E. coli, is a fascinating strain of bacteria that holds immense scientific significance. Belonging to the Enterobacteriaceae family, it inhabits the gastrointestinal tract of humans and animals. While some strains are beneficial for digestion, others can be pathogenic, causing infections and illness. E. coli’s versatile nature and extensive study in microbiology make it a crucial model organism for research, contributing to our understanding of genetics, biochemistry, anad biotechnology.

Market Dynamics:

Biotechnology research, recombinant protein production and pharmaceutical development is anticipated to drive growth of the global Escherichia Coli Strain market over the forecast period. Moreover, industrial processes is also expected to boost the growth of the global Escherichia Coli Strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.

However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the Escherichia Coli Strain market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the Escherichia Coli Strain market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Escherichia Coli Strain market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Escherichia Coli Strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Escherichia Coli Strain Market
Detailed Segmentation:
  • Global Escherichia Coli Strain Market, By Application:
  • Research
  • Industrial
  • Clinical
  • Global Escherichia Coli Strain Market, By Pathogenicity:
  • Pathogenic E. coli
  • Non-pathogenic E. coli
  • Global Escherichia Coli Strain Market, By Antibiotic Resistance:
  • Drug-sensitive strains
  • Drug-resistant strains
  • Global Escherichia Coli Strain Market, By Genetic Characteristics:
  • Wild-type strains
  • Genetically Modified (GM) strains
  • Global Escherichia Coli Strain Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Company Profile:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN N.V.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation

Table of Contents

160 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Application
Market Snapshot, By Pathogenicity
Market Snapshot, By Antibiotic Resistance
Market Snapshot, By Genetic Characteristics
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Biotechnology research
Restraints
Safety and biosecurity concerns
Opportunities
Biopharmaceutical production
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Escherichia Coli Strain Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Escherichia Coli Strain Market , By Application, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Industrial
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Clinical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Escherichia Coli Strain Market , By Pathogenicity, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Pathogenic E. coli
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion )
Non-pathogenic E. coli
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion )
7. Global Escherichia Coli Strain Market , By Antibiotic Resistance, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Drug-sensitive strains
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion )
Drug-resistant strains
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion )
8. Global Escherichia Coli Strain Market , By Genetic Characteristics, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Wild-type strains
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Genetically Modified (GM) strains
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Escherichia Coli Strain Market , By Geography, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Antibiotic Resistance, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Genetic Characteristics, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Antibiotic Resistance, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Genetic Characteristics, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Antibiotic Resistance, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Genetic Characteristics, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Antibiotic Resistance, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Genetic Characteristics, 2023-2030,(US$ Bn)
Middle East and South Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Antibiotic Resistance, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Genetic Characteristics, 2023-2030,(US$ Bn)
10. Competitive Landscape
Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novozymes A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
QIAGEN N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Promega Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Agilent Technologies, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
New England Biolabs, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Takara Bio Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bio-Rad Laboratories, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GenScript Biotech Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Escherichia Coli Strain Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us